• Onyx Scientific Aims for European Growth with New BD Hire

    Jun 13, 2024, 08:51 by
    Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.
    Full story
  • Clinical Trials Adrift in the Age of Social Media

    Jun 13, 2024, 05:00 by User Not Found
    Clinical Research News | Many forces outside of the healthcare setting shape people’s decisions about whether to join or stay in a clinical trial or comply with study-related requirements. While no strong evidence exists that influencers on social media are impacting the integrity of trials, it has become self-evident that they have the power to undermine the authority of traditional sources of information and their sway is therefore an issue “very deserving of our attention."
    Full story
  • CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’

    Jun 12, 2024, 07:19 by
    CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials
    Full story
  • CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

    Jun 12, 2024, 07:19 by
    CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
    Full story
  • Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage

    Jun 11, 2024, 10:48 by
    Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.
    Full story
  • Watching the State of Clinical Trial Data Compliance

    Jun 11, 2024, 05:00 by User Not Found
    Clinical Research News | Until relatively recently, clinical-trial submissions in the EU had to be made separately to each applicable member-state’s authority. The process was inefficient and laborious, resulting in a lot of complaints from clinical-research organizations. On January 31, 2022, the EU Clinical Trials Regulation came into effect.
    Full story
  • CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation

    Jun 7, 2024, 08:08 by
    Full story
  • ‘Continuity’ and Why It’s Now Critical for Successful Ophthalmic Clinical Trials

    Jun 7, 2024, 05:00 by User Not Found
    Clinical Research News | Ophthalmic clinical trials are expanding in global reach, incorporating a wide range of geographical areas, sites, personnel, and imaging technologies. Maintaining data integrity, imaging reliability, process efficiency, and regulatory compliance across these multi-faceted environments can be quite challenging—and is why continuity across image collection, processing, and management is now a fundamental “must-have” for ophthalmic clinical trial success.
    Full story
  • City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program

    Jun 6, 2024, 09:30 by
    Genestack has announced a collaboration with City University of New York (CUNY) to streamline data curation for the BioConductor program, a widely used open-source software project that provides tools for the analysis and comprehension of high-throughput genomic data.
    Full story
  • FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning

    Jun 6, 2024, 09:30 by
    FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials
    Full story
  • AI Model Estimates Treatment Effect on Par With Clinical Trials

    Jun 6, 2024, 05:00 by User Not Found
    Clinical Research News | Researchers at The Ohio State University (OSU) have been using artificial intelligence (AI) for several years now to emulate clinical trials by crunching real-world data (RWD). In their latest computational feat, they succeeded in precisely estimating results of randomized clinical trials comparing the effectiveness of two treatments for reducing the risk of stroke after coronary artery disease.
    Full story
  • Syngene launches platform for rapid, enhanced protein production

    Jun 5, 2024, 07:28 by
    Full story
  • Ardena appoints Jeremie Trochu as Chief Executive Officer

    Jun 4, 2024, 07:40 by
    Ardena has appointed Jeremie Trochu as Chief Executive Officer following the retirement of Harry Christiaens, who will remain on the company's board after 20 years of leadership. Trochu, previously with Catalent, Inc., brings extensive experience in the life sciences and CDMO industry, positioning Ardena for continued growth and international expansion.
    Full story
  • Blood Test Could Improve Diagnosis of Severe Strokes on a Global Scale

    Jun 4, 2024, 05:00 by User Not Found
    Clinical Research News | Researchers at The Ohio State University (OSU) have been using artificial intelligence (AI) for several years now to emulate clinical trials by crunching real-world data (RWD). In their latest computational feat, they succeeded in precisely estimating results of randomized clinical trials comparing the effectiveness of two treatments for reducing the risk of stroke after coronary artery disease.
    Full story
  • AES Clean Technology Announces Appointment of New CEO

    May 31, 2024, 08:35 by
    Full story
  • PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore™ IOP and IHC Explore™ Ahead of ASCO 2024

    May 30, 2024, 08:30 by
    PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. The product pairing provides unprecedented single-cell and spatial resolution of the tumor microenvironment from routine pathology samples to facilitate biomarker discovery and deeper understanding of treatment response for the next generation of cancer therapeutics. The expansion of the Explore™ portfolio comes at a time when AI-pathology is experiencing accelerated large-scale adoption across the diagnostic and biopharma industries.
    Full story
  • Datacubed Health Sharpens Focus on eCOA and ePRO With New CEO

    May 30, 2024, 08:30 by
    Datacubed Health announced the appointment of Kyle Hogan as its new chief executive officer (CEO).
    Full story
  • American Clinical Research Services Acquires Elixia, Oxford BioDynamics, King’s College London Collaborate, Recursion’s Supercomputer Ranked, More

    May 29, 2024, 05:00 by User Not Found
    Clinical Research News | American Clinical Research Services has acquired Elixia; Oxford BioDynamics and King's College London are teaming up in the immediate follow up of the APIPPRA trial, the largest RA prevention trial to date; Recursion’s BioHive-2 was dubbed No. 35 on the latest TOP500 list of the world’s fastest supercomputers; more.
    Full story
  • Creative Enzymes Introduces Leaf-branch Compost Poly (ethylene terephthalate) Hydrolase for Sustainable PET Degradation

    May 28, 2024, 14:58 by
    Full story
  • Creative Enzymes Introduces Recombinant Porcine Citrate Synthase with Enhanced C-His Tag for Accelerated Metabolic Research

    May 28, 2024, 14:58 by
    Full story
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • 49
  • 50
  • »